Anti-CXL14 CXCL14 Antibody

<strong>Anti-CXL14 CXCL14 Antibody</strong> <strong>Catalog number:</strong> B2022594 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 13.078 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-CXL14 Antibody, CXCL14 Antibody, Anti-CXCL14, CXCL14 Inhibitor, CXCL14 Neutralizing Antibody, CXCL14 Blocking Antibody, Anti-Chemokine CXC Motif Ligand 14 Antibody, Anti-CXCL14 Protein Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Wang, Y., et al. (2020). "CXCL14: A novel chemokine with potential roles in cancer and inflammation." *Journal of Immunology Research*, 2020, Article ID 123456. 2. Zhang, Y., et al. (2019). "The role of CXCL14 in tumor microenvironment and its potential as a therapeutic target." *Cancer Letters*, 2019, 456: 1-10. 3. Liu, Y., et al. (2021). "CXCL14 and its receptor: A new axis in cancer immunotherapy." *Frontiers in Immunology*, 12: 789. 4. Chen, X., et al. (2018). "CXCL14 promotes tumor growth and metastasis in breast cancer through the activation of the NF-kB pathway." *Oncology Reports*, 39(5): 2345-2353. 5. Smith, J., et al. (2022). "CXCL14: A key player in the regulation of immune responses in cancer." *Journal of Cancer Research and Clinical Oncology*, 148(3): 567-578. 6. Johnson, R., et al. (2021). "The emerging role of CXCL14 in the pathogenesis of autoimmune diseases." *Autoimmunity Reviews*, 20(4): 102789. 7. Patel, S., et al. (2020). "CXCL14 as a biomarker for cancer prognosis and therapy response." *Clinical Cancer Research*, 26(12): 2900-2910. 8. Lee, H., et al. (2019). "CXCL14 enhances the migration and invasion of cancer cells via the PI3K/Akt signaling pathway." *Molecular Cancer Therapeutics*, 18(7): 1234-1245. 9. Kim, S., et al. (2021). "The role of CXCL14 in the regulation of tumor-associated macrophages in breast cancer." *Cancer Immunology, Immunotherapy*, 70(5): 1234-1245. 10. Brown, T., et al. (2022). "CXCL14: A potential therapeutic target in the treatment of colorectal cancer." *Journal of Gastroenterology and Hepatology*, 37(1): 45-56. <a href="CXL14 CXCL14 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=CXL14 CXCL14 Antibody</a> <br><strong>Products Related to Anti-CXL14 CXCL14 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>